Corin Wagen

In this engaging discussion, Corin Wagen, co-founder of Rowan, a breakthrough molecular simulation company, shares insights alongside his brother Ari. They delve into neural network potentials and their potential to revolutionize drug design and materials science. The conversation tackles the dichotomy between classical and quantum simulations, along with the importance of improved accuracy in computational chemistry. Corin and Ari also explore the challenges of benchmarking simulations and the role of AI in enhancing molecular dynamics, making a complex field more accessible.